Listing & Compliance Notices

GLOBALINK INVESTMENT INC. received a nasdaq delisting notice notice regarding other (rules IM-5101-2).

“December 10, 2024, Globalink Investment Inc., a Delaware corporation (the “Company”), received a notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) that the Company was not in compliance with Nasdaq Listing Rule IM-5101-2, which requires a special purpose acquisition company to complete one or more business combinations within 36 months of the effectiveness of its IPO registration statement. Since the Company failed to complete its initial business combination by December 6, 2024, the Company did not comply with IM-5101-2, which triggered the”

Australian Oilseeds Holdings Ltd received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)(A)).

“10-K for the period ended June 30, 2024 was AUD $907,569. Based on the currency conversion rate from AUD to USD as of June 30, 2024, the shareholders’ equity was approximately $605,258. In accordance with Nasdaq rules and as stated in the Letter, the Company has until January 21, 2025 (45 calendar days from the date of the Letter) to submit a plan to regain”

Golden Minerals Co received a nyse_american delisting notice notice regarding stockholders equity (rules 1003(a)(i), 1003(a)(ii), 1003(a)(iii)).

“December 6, 2024, Golden Minerals Company (the “Company”) received notification from the NYSE American LLC (the “NYSE American” or the “Exchange”) that the Exchange determined to commence proceedings to suspend and delist the Company’s common stock as a result of its determination that the Company is no longer suitable for listing due to its non-compliance with Sections 1003(a)(i), 1003(a)(ii) and 1003(a)(iii) of the NYSE American Company Guide, which require the Company to report stockholders’ equity of $6.0 million or more if the Company has reported losses from continuing operations and/or”

USBC, Inc. received a nyse_american extension granted notice regarding stockholders equity (rules 1003(a)(ii), 1003(a)(iii)).

“December 10, 2024, Know Labs, Inc. (the “Company”) received notice from the NYSE American LLC (“NYSE American”) that it had accepted the Company’s plan to regain compliance with the NYSE American continued listing standards and granted a plan period through March 27, 2026 (“Extension Date”). As previously disclosed on September 27, 2024, the Company received a letter from the NYSE American stating that the Company was not in compliance with the continued listing standards set forth in Sections 1003(a)(ii) and 1003(a)(iii) of the NYSE American Company Guide, which require stockholders’ equity o”

TALPHERA, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“December 6, 2024, Talphera, Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Staff of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1) for continued listing on The Nasdaq Global Market. Nasdaq Listing Rule 5450(a)(1) requires listed securities to maintain a minimum bid price of $1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a p”

Nuburu, Inc. received a nyse_american deficiency notice notice regarding other (rules 301, 713).

“December 5, 2024, Nuburu, Inc. (the “Company”) received from NYSE Regulation a Warning Letter (the “Letter”) as provided under Section 1009(a) of the NYSE American LLC Company Guide (the “Company Guide”) describing violations by the Company of Sections 301 and 713 of the Company Guide. Section 301 of the Company Guide prohibits a listed company from issuing, or authorizing its transfer agent or registrar to issue or register, additional securities of a listed class until it has filed an application for the listing of such additional securities and received notification from the NYSE American t”

Spectral AI, Inc. received a nasdaq delisting notice notice regarding market value (rules 5550(b)(2)).

“December 5, 2024, the Company received a letter from Nasdaq notifying it that the Company’s Common Stock would be subject to delisting from the Nasdaq Stock Market unless the Company timely requested a hearing before the Nasdaq Listing Qualifications Panel (the “Panel”). Based on the foregoing, the Company has requested a hearing before the Panel, at which it will present its plan of compliance and request an extension of time. The Panel has the discretion to grant the Company up to 180 calendar days from December 2, 2024, to regain compliance. This request will automatically stay any delistin”

Ocean Biomedical, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).

“December 5, 2024, Nasdaq sent a letter to the Company notifying it that based upon the Company’s MVLS for the last 30 consecutive business days, the Company no longer meets this requirement. Consequently, a deficiency exists with regard to the Rule. However, the Rules also provide the Company a compliance period of 180 calendar days in which to regain compliance. If at anytime during this compliance period the Company’s MVLS closes at $35 million or more for a minimum of ten consecutive business days, Nasdaq will provide written confirmation of compliance and this matter will be closed. In the”

ECD Automotive Design, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“December 6, 2024, ECD Automotive Design, Inc. (the “Company”) received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the Company is delinquent in filing its Form 10-Q for the quarter ended September 30, 2024, the Company no longer complies with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires companies with securities listed on Nasdaq to timely file all required periodic reports with the SEC. The Notice provided that the Company shall have 60 calendar days to submit a plan to regain compliance with the Listing Rule, a”

Four Leaf Acquisition Corp received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“November 21, 2024, from the Nasdaq Listing Qualifications Department (“Nasdaq”) indicating that the Company remains in non-compliance with the timely filing requirement for continued listing under Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission. The Notice will have no immediate effect on the listing or trading of the Company’s common stock, although there can be no assurances that further delays in the filing of the Form 10-Q will not have an impact on the listing or trading of the Company”

MARINUS PHARMACEUTICALS, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“December 6, 2024, Marinus Pharmaceuticals, Inc. (the “Company”) received written notice (the “Bid Price Deficiency Notice”) from The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that for the previous 30 consecutive business days, the bid price for the Company’s common stock, par value $0.001 (the “Common Stock”), had closed below the $1.00 per share minimum bid price requirement for continued listing on The Nasdaq Global Market, as set forth in Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”). The Bid Price Deficiency Notice has no effect at this time on the li”

QVC Group, Inc. received a nasdaq extension granted notice regarding minimum bid price.

“December 10, 2024, Nasdaq granted the Company an additional 180-day extension, or until June 9, 2025 (the “New Compliance Date”) to comply with the Minimum Bid Price Requirement. If, at any time before the New Compliance Date, the bid price of QRTEA is at least $1.00 for a minimum of 10 consecutive business days, Nasdaq will provide written confirmation of compliance to the Company and this matter will be closed with respect to the Minimum Bid Price Requirement. The Company will continue to actively monitor the closing bid price of QRTEA and will evaluate available options to resolve the defic”

Container Store Group, Inc. received a nyse delisting notice notice regarding market value (rules 802.01B).

“December 9, 2024, the New York Stock Exchange (the “NYSE”) notified The Container Store Group, Inc. (the “Company”), that it had determined to commence proceedings to delist the Company’s common stock, par value $0.01 per share and Preferred Stock Purchase Rights (the “Company’s Stock”), as a result of the Company’s non-compliance with Rule 802.01B of the NYSE Listed Company Manual, which requires listed companies to maintain an average global market capitalization over a consecutive 30 trading day period of at least $15 million. Trading in the Company’s Stock on the NYSE was suspended after m”

TFF Pharmaceuticals, Inc. received a nasdaq delisting notice notice regarding other (rules 5101, 5110(b)).

“December 4, 2024, TFF Pharmaceuticals, Inc. (“Company”) received a determination letter (the “Delisting Notification”) from the Nasdaq Stock Market (“Nasdaq”) stating that the Nasdaq staff determined, in accordance with Nasdaq Listing Rules 5101 and 5110(b) and Nasdaq Listing Rule IM 5101-1, that the Company’s common stock will be delisted from The Nasdaq Stock Market. The Delisting Notification states that the Nasdaq staff’s determination was based on (i) the Company’s previously announced Plan of Dissolution and associated public interest concerns raised by it; (ii) concerns regarding the re”

CISO Global, Inc. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“December 5, 2024, we received written notification from Nasdaq notifying us that we had regained compliance with Nasdaq Listing Rule 5550(a)(2) as a result of the closing bid price of our common stock being at $1.00 per share or grater for the last 10 consecutive business days. Accordingly, we are now in compliance with Nasdaq Listing Rule 5550(a)(2) and Nasdaq considers the matter closed.”

iLearningEngines, Inc. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“December 4, 2024, iLearningEngines , Inc. (the “ Company ”) received a delinquency notification letter (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that due to the delay in filing the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the “ Form 10-Q ”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “ Rule ”), which requires listed companies to timely file all periodic financial reports with the Securities and Exchange Commission (the “ SEC ”). The Notice”

SemiLEDs Corp received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“December 4, 2024, the Company received a separate notice from The NASDAQ Stock Market indicating that the Company does not meet the minimum of $2,500,000 in stockholders’ equity required by Listing Rule 5550(b)(1) for continued listing. The Company also does not meet the alternatives of market value of listed securities or net income from continuing operations. Under the listing rule, the Company has 45 calendar days to submit a plan to regain compliance. If the plan is accepted by The NASDAQ Stock Market, an extension of up to 180 calendar days from December 4, 2024 will be granted. 2 SIGNATU”

Ocean Biomedical, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“December 3, 2024, Ocean Biomedical, Inc.. (the “Company”) received a letter from Nasdaq that it no longer complies with Rule 5550(a)(2) of Nasdaq’s Listing Rules (the “Rules”) which require listed securities to maintain a minimum bid price of $1 per share. Based upon the closing bid price for the last 30 consecutive business days (October 21, 2024 to December 2, 2024), the Company no longer meets this requirement. However, the Rules also provide the Company a compliance period of 180 calendar days (until June 2, 2025) in which to regain compliance. Pursuant to Rule 5810(c)(3)(C) if at any time”

Roth CH Acquisition V Co. received a nasdaq deficiency notice notice regarding other.

“December 2, 2024, the Company received a notice from the staff of the Listing Qualifications Department of Nasdaq stating that because the Company had not completed an initial business combination within 36 months of the effective date of its registration statement in connection with its initial public offering, it was not in compliance with Nasdaq IM 5101-2, and was therefore subject to delisting. The Company has until December 9, 2024 to request a hearing before the Nasdaq Hearings Panel. Trading in the Company’s securities on Nasdaq will be suspended at the opening of business on December 9”

Presidio Property Trust, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“listing of the Company’s common stock, which will continue to be listed and traded on the Nasdaq Capital Market, subject to the Company’s compliance with the other listing requirements of the Nasdaq Capital Market. Although the Company will use all reasonable efforts to achieve compliance with Rule 5550(a)(2), there can be no assurance that the Company will be able to regain compliance with that rule or will otherwise be in compliance with other listing criteria of the Nasdaq Capital Market.”

Super Micro Computer, Inc. received a nasdaq extension granted notice regarding late filing (rules 5250(c)(1)).

“December 6, 2024, Super Micro Computer, Inc. (the “Company”) received a letter (the “Letter”) from the Nasdaq Stock Market (“Nasdaq”) informing the Company that Nasdaq has granted the Company’s request for an exception to Nasdaq’s Listing Rule 5250(c)(1) through February 25, 2025. The exception gives the Company until February 25, 2025 to file its Annual Report on Form 10-K for the fiscal year ended June 30, 2024, its Quarterly Report on Form 10-Q for the period ended September 30, 2024 and any other required filings. The Company’s common stock will remain listed on the Nasdaq Global Select Ma”

Energous Corp received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“December 4, 2024, Energous Corporation d/b/a Energous Wireless Power Solutions (the “Company”) received notice (the “Notice”) from the staff of the Listing Qualifications department (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) indicating the Company that the Company was not in compliance with the minimum stockholders’ equity requirement for continued listing as set forth in Nasdaq Listing Rule 5550(b)(1) (the “Stockholders’ Equity Requirement”), because the Company’s stockholders’ equity of $434,000, as reported in the Company’s Quarterly Report on Form 10-Q for the quarterly period end”

Canoo Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“December 4, 2024, Canoo, Inc. (the “Company”) received notice from The Nasdaq Stock Market (“ Nasdaq ”) that the closing bid price for our common stock had been below $1.00 per share for the previous 30 consecutive business days, and that we are therefore not in compliance with the minimum bid price requirement for continued inclusion on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (“ Rule 5550(a)(2) ”). Nasdaq’s notice has no immediate effect on the listing or trading of our common stock on The Nasdaq Capital Market. The notice indicates that we will have 180 calendar days”

Independence Contract Drilling, Inc. received a otc delisting notice notice regarding other.

“December 3, 2024 based on the Company filing the Chapter 11 Cases. As a result of the delisting, the Company commenced trading on the OTC Pink Market on December 4, 2024. The Company can provide no assurance that its common stock will continue to trade on this market, whether broker-dealers will continue to provide public quotes of the common stock on this market, or whether the trading volume of the common stock will be sufficient to provide for an efficient trading market. The transition to OTC Pink Market will not affect the Company’s business operations. ​ Cautionary Statement Regarding Fo”

Investcorp AI Acquisition Corp. received a nasdaq noncompliance notice notice regarding market value (rules 5450(b)(3)(A)).

“November 29, 2024, Investcorp AI Acquisition Corp., a Cayman Islands exempted company (the “ Company ”) received a notification letter (the “ Notification Letter ”) from the Listing Qualifications Department (the “ Staff ”) of the Nasdaq Stock Market LLC (“ Nasdaq ”) indicating that the Company’s listed securities fail to comply with the minimum of $50,000,000 market value of listed securities (“ MVLS ”) requirement for continued listing on the Nasdaq Global Market in accordance with Nasdaq Listing Rule 5450(b)(3)(A) (the “ Rule ”) based upon the Company’s MVLS from September 27, 2024 to Novem”

TLGY ACQUISITION CORP received a nasdaq delisting notice notice regarding other (rules IM-5101-2).

“December 2, 2024, TLGY Acquisition Corporation (the “Company”) received a notice from the staff of the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company had not completed an initial business combination within 36 months of the effective date of its registration statement in connection with its initial public offering, it was not in compliance with Nasdaq IM 5101-2, and was therefore subject to delisting. The Company has until December 9, 2024 to request a hearing before the Nasdaq Hearings Panel (the “Panel”), but will not request a he”

ENGLOBAL CORP received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)).

“December 5, 2024, ENGlobal Corporation (the “Company) received written notice from The Nasdaq Stock Market (“Nasdaq”) indicating the Company failed to regain compliance with Listing Rule 5550(b), the minimum shareholders’ equity rule. The notice further indicates the Nasdaq Hearings Panel (the “Panel”) has determined to delist the Company’s common stock and that trading of the Company’s common stock will be suspended at the open of trading on December 6, 2024. As previously disclosed, on August 14, 2024, the Company received written notice from Nasdaq notifying the Company that the Panel had d”

WINDTREE THERAPEUTICS INC /DE/ received a nasdaq deficiency notice notice regarding board independence (rules 5605(b)(1), 5605(c)(2)(A)).

“December 4, 2024, the Company received a notice (the “ Audit Committee & Board Independence Notice ”) from the Nasdaq Listing Qualifications Department (the “ Staff ”) indicating that the Company no longer complies with the (i) Majority Independent Board Standard as set forth in Nasdaq Listing Rule 5605(b)(1) and (ii) Audit Committee Composition Standard as set forth in Nasdaq Listing Rule 5605(c)(2)(A). The Company is in the process of reviewing and evaluating potential options to regain compliance with these continued listing requirements noted above in a manner consistent with the cure peri”

SHINECO, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“November 26, 2024, Shineco Inc. (the “Company”) received a deficiency letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based upon the closing bid price of the Company’s common stock (the “Common Stock”) for the last 30 consecutive business days prior to September 3, 2024, the Company was not in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2). Since then, Nasdaq has determined t”

NKGen Biotech, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C)).

“December 2, 2024, NKGen Biotech, Inc. (the “ Company ”) received written notice (the “ MVPHS Notice ”) from the Listing Qualifications Staff of the Nasdaq Stock Market, LLC (“ Nasdaq ”) notifying the Company that, based on the market value of publicly held shares for the previous 30 consecutive business days, the Company is not in compliance with Nasdaq Listing Rule 5450(b)(2)(C), which requires the Company’s listed securities to maintain a minimum market value of publicly held shares of $15,000,000 (the “ MVPHS Requirement ”). The MVPHS Notice has no immediate effect on the listing of the Com”

Cartica Acquisition Corp received a nasdaq deficiency notice notice regarding audit committee (rules 5605).

“November 27, 2024, Cartica Acquisition Corp (the “Company”) received a written notice (the “Notice”) from The Nasdaq Stock Market (“Nasdaq”) indicating that the Company no longer complies with Nasdaq Listing Rule 5605 (the “Audit Committee Listing Rule”), which requires, among other things, companies with securities listed on Nasdaq to have an audit committee consisting of at least three members who are independent directors. The Company fell out of compliance with the Audit Committee Listing Rule as a result of the vacancy caused by the resignation of Kyle Ingvald Parent from the board of dir”

Chenghe Acquisition I Co. received a nasdaq deficiency notice notice regarding other (rules 5450(a)(2)).

“November 27, 2024, Chenghe Acquisition I Co. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Company is not in compliance with Listing Rule 5450(a)(2) (the “Minimum Public Holders Rule”), which requires the Company to maintain a minimum of 400 total holders for continued listing on the Nasdaq Global Market. An indicator reflecting the Company’s non-compliance will be broadcast over Nasdaq’s market data dissemination network and will also be made available t”

Cardio Diagnostics Holdings, Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“December 4, 2024 (the "Second Nasdaq Bid Price Letter”), Nasdaq notified the Company that Nasdaq’s Staff has determined that the Company is eligible for an additional 180 calendar day period, or until June 2, 2025, to regain compliance (the "Second Compliance Period”). The determination is based on the Company’s meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on The Nasdaq Capital Market with the exception of the Minimum Bid Price Requirement, and the Company’s written notice of its intention to cure t”

FutureTech II Acquisition Corp. received a nasdaq deficiency notice notice regarding market value (rules 5420(a)(2), 5450(b)(2)(B)).

“November 27, 2024 (the “ Notice ”). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “ Listing Rule ”) as a result of its failure to timely file the Q3 10-Q. The Staff also noted that this serves as an additional basis for delisting the Company’s securities from Nasdaq and since the Company is already before a Hearings Panel for its failure to comply with the Market Value of Listed Securities requirement of Nasdaq Listing Rule 5420(a)(2) (the “ Market Value of Listed Shares Rule ”), the Company has until December 4, 2024 to request a stay of”

FutureTech II Acquisition Corp. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“November 27, 2024 (the “ Notice ”). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “ Listing Rule ”) as a result of its failure to timely file the Q3 10-Q. The Staff also noted that this serves as an additional basis for delisting the Company’s securities from Nasdaq and since the Company is already before a Hearings Panel for its failure to comply with the Market Value of Listed Securities requirement of Nasdaq Listing Rule 5420(a)(2) (the “ Market Value of Listed Shares Rule ”), the Company has until December 4, 2024 to request a stay of”

HEARTLAND EXPRESS INC received a nasdaq deficiency notice notice regarding audit committee (rules 5605, 5605(c)(4)).

“November 29, 2024, the Company received a notice (the “Notice”) from the Listing Qualifications Staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that, as a result of Mr. Sullivan’s passing, the Company is no longer in compliance with Nasdaq Listing Rule 5605, which, in relevant part, requires the Audit and Risk Committee to consist of at least three members, each of whom must be an independent director under the Nasdaq Listing Rules and meet the heightened independence standards for audit committee members under the Nasdaq Listing Rules and the Securities Exchange Act of 1934”

QVC Group, Inc. received a nasdaq deficiency notice notice regarding minimum bid price.

“June 10, 2024, the Company received written notice from Nasdaq notifying the Company that, based on the closing bid price for QRTEA for 30 consecutive business days, the Company no longer complied with the minimum bid price requirement for continued listing of QRTEA on the Nasdaq Global Select Market (the “Minimum Bid Price Requirement”). The Company thereafter had 180 calendar days, or until December 9, 2024 (the “Initial Compliance Date”), to regain compliance with the Minimum Bid Price Requirement or to transfer to the Nasdaq Capital Market and request an additional 180-day extension from t”

Independence Contract Drilling, Inc. received a otc delisting notice notice regarding other.

“December 2, 2024, the OTCQX Best Market (“OTCQX”) notified the Company that it was no longer compliant with the OTCQX’s minimum market capitalization rule, which requires the Company to maintain an average market capitalization of $5 million over a consecutive 30-day trading period. The OTCQX rules provide for a cure period of 90 calendar days to regain compliance, which cure period begins upon failure to meet the market capitalization rule. During such period, the applicable criteria must be met for ten consecutive trading days. Such cure period is set to expire March 3, 2025. If at that time”

Independence Contract Drilling, Inc. received a otc deficiency notice notice regarding market value.

“December 2, 2024, the OTCQX Best Market (“OTCQX”) notified the Company that it was no longer compliant with the OTCQX’s minimum market capitalization rule, which requires the Company to maintain an average market capitalization of $5 million over a consecutive 30-day trading period. The OTCQX rules provide for a cure period of 90 calendar days to regain compliance, which cure period begins upon failure to meet the market capitalization rule. During such period, the applicable criteria must be met for ten consecutive trading days. Such cure period is set to expire March 3, 2025. If at that time”

MSP Recovery, Inc. received a nasdaq compliance regained notice regarding minimum bid price (rules 5450(a)(1)).

“December 3, 2024, MSP Recovery, Inc. (“the Company”) received correspondence from Nasdaq stating that the Company’s previously disclosed bid price deficiency has been cured, and that the Company has regained compliance with Listing Rule 5450(a)(1). The Company’s Class A common stock will continue to be listed and traded on Nasdaq, subject to continued compliance with applicable Nasdaq listing standards.”

Amesite Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“November 26, 2024, Amesite Inc. (“Amesite” or “the Company”) received a deficiency letter (the “Nasdaq Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires the Company to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing on the Nasdaq Capital Market (the “Stockholders’ Equity Requirement”), nor is it in compliance with either of the alternative listing standards, either a market value of listed securities of at least $35 mi”

ATI Physical Therapy, Inc. received a nyse delisting notice notice regarding market value (rules 802.01B).

“December 3, 2024, the New York Stock Exchange (the “NYSE”) notified ATI Physical Therapy, Inc. (“ATI” or the “Company”) that it has determined to commence proceedings to delist the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”), as a result of the Company’s non-compliance with Rule 802.01B of the NYSE Listed Company Manual that requires listed companies to maintain an average global market capitalization of at least $15 million over a period of 30 consecutive trading days. Trading in the Common Stock on the NYSE was suspended after market close on December 3”

ALPHATIME ACQUISITION CORP received a nasdaq deficiency notice notice regarding other (rules 5450(a)(2)).

“November 29, 2024, AlphaTime Acquisition Corp (the “ Company ”) received a written notice (the “ Notice ”) from the Listing Qualifications Department (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that the Company is not in compliance with Listing Rule 5450(a)(2) (the “ Minimum Public Holders Rule ”), which requires the Company to have at least 400 total holders for continued listing on The Nasdaq Global Market. An indicator will be displayed with quotation information related to the Company’s securities on listingcenter.nasdaq.com and may be displayed by oth”

Vyome Holdings, Inc received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“November 25, 2024, ReShape Lifesciences Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications department (the “Nasdaq Staff”) of the Nasdaq Stock Market (“Nasdaq”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on the Nasdaq Capital Market to maintain a minimum of $2.5 million in stockholders’ equity for continued listing. As of September 30, 2024, the Company’s stockholders’ equity was $1,487,000. Under the Nasdaq Listing Rules the Company has 45 calendar days to submit a plan to reg”

Plum Acquisition Corp. III received a nasdaq deficiency notice notice regarding late filing (rules IM-5101-2).

“ter serves as an additional basis for delisting the Company’s securities from the Nasdaq in light of the Company’s previously reported failure to complete one or more business combinations within 36 months of the effectiveness of its IPO registration statement in accordance with Nasdaq Listing Rule IM-5101-2.”

Viracta Therapeutics, Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).

“November 26, 2024, the Staff issued a delist determination to the Company (the “Delisting Notice”), indicating that the Company did not satisfy the Minimum Bid Price Requirement by the Compliance Date. The Delisting Notice indicated that the Company was not eligible for a second 180-day extension because it did not comply with the Stockholders’ Equity Requirement. The Company intends to request a hearing (the “Hearing”) before the Nasdaq Listing Qualifications Panel (the “Panel”) to appeal (the “Appeal”) the determination by the Staff, and to present its plan to regain and sustain compliance w”

Viracta Therapeutics, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

“November 26, 2024, the Staff issued a delist determination to the Company (the “Delisting Notice”), indicating that the Company did not satisfy the Minimum Bid Price Requirement by the Compliance Date. The Delisting Notice indicated that the Company was not eligible for a second 180-day extension because it did not comply with the Stockholders’ Equity Requirement. The Company intends to request a hearing (the “Hearing”) before the Nasdaq Listing Qualifications Panel (the “Panel”) to appeal (the “Appeal”) the determination by the Staff, and to present its plan to regain and sustain compliance w”

TALPHERA, INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5450(b)(1)(A)).

“November 27, 2024, Talphera, Inc. (the “Company”) received a written notice from the Listing Qualifications Staff of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, based on the Company’s stockholders’ equity of $9,641,000 as of September 30, 2024, as reported in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, the Company is no longer in compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(1)(A), which requires companies to maintain stockholders’ equi”

AVENUE THERAPEUTICS, INC. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).

“least $2,500,000 (the “Stockholders’ Equity Requirement”). The Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2024 reported stockholders’ equity of $1,652,000. In a decision dated June 3, 2024, a Nasdaq Hearings Panel (the “Panel”) previously had confirmed that the Company regained compliance with the Stockholders’ Equity”

Celularity Inc received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“November 21, 2024, the Company informed the Listing Qualifications department of the Nasdaq Stock Market LLC (“Nasdaq”) that it failed to timely file its Q3 2024 Form 10-Q within the extension period provided by Rule 12b-25 because the Company had not yet completed the preparation of the financial statements. On November 21, 2024, Nasdaq provided formal notice to the Company that as a result of the Company’s failure to timely file its Q3 2024 10-Q, it no longer complied with the continued listing requirements under the timely filing criteria outlined in Nasdaq Listing Rule 5250(c)(1). Nasdaq’s”